AstraZeneca working with Mass General on tech for heart failure, asthma

The biotechnology company AstraZeneca announced on Tuesday that it would be collaborating with Massachusetts General Hospital to create and clinically validate patient-centric digital health solutions. According to the company, the collaboration will use AstraZeneca’s new AMAZE disease management platform to study heart failure and asthma management.   “We are incredibly proud to be working closely… Read More »

AstraZeneca vaccine side effects: Blood clot risk appears to be ‘age related’ – Professor

The UK’s vaccination rates are the envy of the world, with more than 31 million people now jabbed with a first dose. The situation is far less rosy in the EU with countries hamstrung by supply shortages. Supplies that have made it into countries remain largely unused thanks to fears over blood clots. Germany has… Read More »

FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia

FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia Morristown, N.J. March 31, 2021 — Althera Pharmaceuticals, a company focused on heart health, today announced the FDA approval of Roszet (rosuvastatin and ezetimibe) tablets, as an adjunct to diet, for treatment of elevated low-density lipoprotein cholesterol (LDL-C) in adult… Read More »